Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
Author(s) -
Matthew J. Crowley,
Darren K. McGuire,
Anastasia-Stefania Alexopoulos,
Thomas Jensen,
Søren Rasmussen,
Hans A. Saevereid,
Subodh Verma,
John B. Buse
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc20-0437
Subject(s) - liraglutide , medicine , metformin , type 2 diabetes , myocardial infarction , hazard ratio , diabetes mellitus , post hoc analysis , placebo , stroke (engine) , endocrinology , mechanical engineering , confidence interval , alternative medicine , pathology , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom